Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

P53 regulates the migration of mesenchymal stromal cells in response to the tumor microenvironment through both CXCL12-dependent and -independent mechanisms.

Lin SY, Dolfi SC, Amiri S, Li J, Budak-Alpdogan T, Lee KC, Derenzo C, Banerjee D, Glod J.

Int J Oncol. 2013 Dec;43(6):1817-23. doi: 10.3892/ijo.2013.2109. Epub 2013 Sep 23.

PMID:
24064862
[PubMed - in process]
Free PMC Article
2.

Protein kinase C zeta regulates interleukin-8-mediated stromal-derived factor-1 expression and migration of human mesenchymal stromal cells.

Picinich SC, Glod JW, Banerjee D.

Exp Cell Res. 2010 Feb 15;316(4):593-602. doi: 10.1016/j.yexcr.2009.11.011. Epub 2009 Nov 24.

PMID:
19944094
[PubMed - indexed for MEDLINE]
3.

Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells.

Menon LG, Picinich S, Koneru R, Gao H, Lin SY, Koneru M, Mayer-Kuckuk P, Glod J, Banerjee D.

Stem Cells. 2007 Feb;25(2):520-8. Epub 2006 Oct 19.

PMID:
17053212
[PubMed - indexed for MEDLINE]
Free Article
5.

Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer.

Shinagawa K, Kitadai Y, Tanaka M, Sumida T, Onoyama M, Ohnishi M, Ohara E, Higashi Y, Tanaka S, Yasui W, Chayama K.

Int J Cancer. 2013 Feb 15;132(4):813-23. doi: 10.1002/ijc.27735. Epub 2012 Aug 6.

PMID:
22821812
[PubMed - indexed for MEDLINE]
6.

Endothelial nitric oxide synthase promotes bone marrow stromal cell migration to the ischemic myocardium via upregulation of stromal cell-derived factor-1alpha.

Li N, Lu X, Zhao X, Xiang FL, Xenocostas A, Karmazyn M, Feng Q.

Stem Cells. 2009 Apr;27(4):961-70. doi: 10.1002/stem.6. Erratum in: Stem Cells. 2013 May;31(5):1030.

PMID:
19353524
[PubMed - indexed for MEDLINE]
Free Article
7.

p53 Attenuates cancer cell migration and invasion through repression of SDF-1/CXCL12 expression in stromal fibroblasts.

Moskovits N, Kalinkovich A, Bar J, Lapidot T, Oren M.

Cancer Res. 2006 Nov 15;66(22):10671-6.

PMID:
17108103
[PubMed - indexed for MEDLINE]
Free Article
8.

p53 activation of mesenchymal stromal cells partially abrogates microenvironment-mediated resistance to FLT3 inhibition in AML through HIF-1α-mediated down-regulation of CXCL12.

Kojima K, McQueen T, Chen Y, Jacamo R, Konopleva M, Shinojima N, Shpall E, Huang X, Andreeff M.

Blood. 2011 Oct 20;118(16):4431-9. doi: 10.1182/blood-2011-02-334136. Epub 2011 Aug 25.

PMID:
21868571
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Osteopontin promotes CCL5-mesenchymal stromal cell-mediated breast cancer metastasis.

Mi Z, Bhattacharya SD, Kim VM, Guo H, Talbot LJ, Kuo PC.

Carcinogenesis. 2011 Apr;32(4):477-87. doi: 10.1093/carcin/bgr009. Epub 2011 Jan 20.

PMID:
21252118
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Migration of human umbilical cord blood mesenchymal stem cells mediated by stromal cell-derived factor-1/CXCR4 axis via Akt, ERK, and p38 signal transduction pathways.

Ryu CH, Park SA, Kim SM, Lim JY, Jeong CH, Jun JA, Oh JH, Park SH, Oh WI, Jeun SS.

Biochem Biophys Res Commun. 2010 Jul 16;398(1):105-10. doi: 10.1016/j.bbrc.2010.06.043. Epub 2010 Jun 15.

PMID:
20558135
[PubMed - indexed for MEDLINE]
11.

Interleukin-1β promotes ovarian tumorigenesis through a p53/NF-κB-mediated inflammatory response in stromal fibroblasts.

Schauer IG, Zhang J, Xing Z, Guo X, Mercado-Uribe I, Sood AK, Huang P, Liu J.

Neoplasia. 2013 Apr;15(4):409-20.

PMID:
23555186
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Breast carcinoma cells modulate the chemoattractive activity of human bone marrow-derived mesenchymal stromal cells by interfering with CXCL12.

Wobus M, List C, Dittrich T, Dhawan A, Duryagina R, Arabanian LS, Kast K, Wimberger P, Stiehler M, Hofbauer LC, Jakob F, Ehninger G, Anastassiadis K, Bornhäuser M.

Int J Cancer. 2014 May 8. doi: 10.1002/ijc.28960. [Epub ahead of print]

PMID:
24806942
[PubMed - as supplied by publisher]
13.

Impact of lenalidomide on the functional properties of human mesenchymal stromal cells.

Wobus M, Benath G, Ferrer RA, Wehner R, Schmitz M, Hofbauer LC, Rauner M, Ehninger G, Bornhäuser M, Platzbecker U.

Exp Hematol. 2012 Oct;40(10):867-76. doi: 10.1016/j.exphem.2012.06.004. Epub 2012 Jun 15.

PMID:
22705469
[PubMed - indexed for MEDLINE]
14.

COX-2 and prostaglandin EP3/EP4 signaling regulate the tumor stromal proangiogenic microenvironment via CXCL12-CXCR4 chemokine systems.

Katoh H, Hosono K, Ito Y, Suzuki T, Ogawa Y, Kubo H, Kamata H, Mishima T, Tamaki H, Sakagami H, Sugimoto Y, Narumiya S, Watanabe M, Majima M.

Am J Pathol. 2010 Mar;176(3):1469-83. doi: 10.2353/ajpath.2010.090607. Epub 2010 Jan 28.

PMID:
20110411
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro.

Guiducci S, Manetti M, Romano E, Mazzanti B, Ceccarelli C, Dal Pozzo S, Milia AF, Bellando-Randone S, Fiori G, Conforti ML, Saccardi R, Ibba-Manneschi L, Matucci-Cerinic M.

Ann Rheum Dis. 2011 Nov;70(11):2011-21. doi: 10.1136/ard.2011.150607. Epub 2011 Aug 6.

PMID:
21821866
[PubMed - indexed for MEDLINE]
16.

Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma.

Niess H, Bao Q, Conrad C, Zischek C, Notohamiprodjo M, Schwab F, Schwarz B, Huss R, Jauch KW, Nelson PJ, Bruns CJ.

Ann Surg. 2011 Nov;254(5):767-74; discussion 774-5. doi: 10.1097/SLA.0b013e3182368c4f.

PMID:
22042469
[PubMed - indexed for MEDLINE]
17.

Stromal fibroblasts in cancer: a novel tumor-promoting cell type.

Orimo A, Weinberg RA.

Cell Cycle. 2006 Aug;5(15):1597-601. Epub 2006 Aug 1. Review.

PMID:
16880743
[PubMed - indexed for MEDLINE]
Free Article
18.

Atmospheric oxygen inhibits growth and differentiation of marrow-derived mouse mesenchymal stem cells via a p53-dependent mechanism: implications for long-term culture expansion.

Boregowda SV, Krishnappa V, Chambers JW, Lograsso PV, Lai WT, Ortiz LA, Phinney DG.

Stem Cells. 2012 May;30(5):975-87. doi: 10.1002/stem.1069.

PMID:
22367737
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

p53 regulates mesenchymal stem cell-mediated tumor suppression in a tumor microenvironment through immune modulation.

Huang Y, Yu P, Li W, Ren G, Roberts AI, Cao W, Zhang X, Su J, Chen X, Chen Q, Shou P, Xu C, Du L, Lin L, Xie N, Zhang L, Wang Y, Shi Y.

Oncogene. 2013 Aug 26. doi: 10.1038/onc.2013.355. [Epub ahead of print]

PMID:
23975435
[PubMed - as supplied by publisher]
20.

Stromal derived factor-1 regulates bone morphogenetic protein 2-induced osteogenic differentiation of primary mesenchymal stem cells.

Hosogane N, Huang Z, Rawlins BA, Liu X, Boachie-Adjei O, Boskey AL, Zhu W.

Int J Biochem Cell Biol. 2010 Jul;42(7):1132-41. doi: 10.1016/j.biocel.2010.03.020. Epub 2010 Mar 31.

PMID:
20362069
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk